Menu
  • Video
  • Audio
  • Images
  • Collections
  • About
Sign in
ASRS A project from the American Soceity of Retina Specialists
Share feedback      Sign in
ASRS Multimedia Library
ASRS A project from the American Society of Retina Specialists
Search by condition, keyword, or author name
  • Video
  • Audio
  • Images
  • Collections
  • About
  1. Collections
  2. Updates from the Field

Sign in to view content

Sign in

Brolucizumab for the treatment of visual impairment due to diabetic macular edema: 52-week results from the KITE and KESTREL studies

  • David M. Brown, MD
  • Video
  • Published 2021

Related

  • Prospective Evaluation of Pain and Inflammation Following Injection of Aflibercept or Ranibizumab in Patients With Diabetic Macular Edema: SOLAR Study

    Nikolas JS London, MD, FACS, FASRS

    Annual Meeting Talks

    2018

  • Diabetic Retinopathy Take Home Panel

    Annual Meeting Talks

    2020

  • Efficacy, Safety, and Durability of Faricimab in Diabetic Macular Edema (DME): One-Year Results From the Phase 3 YOSEMITE and RHINE Trials

    Caroline Baumal, MD

    Annual Meeting Talks

    2021

Category: Pharmacology

  • Diabetic Macular Edema
  • intravitreal aflibercept
  • Anti VEGF

See more

  • Updates from the Field
  • David M. Brown, MD
  • ASRS Multimedia Library
  • Video
  • Audio
  • Images
  • Collections
American Society of Retina Specialists20 North Wacker Drive, Suite 2030,Chicago, Illinois 60606(312) 578-8760 phoneinfo@asrs.org
© 2025 The American Society of Retina Specialists. All rights reserved. Privacy statement. Terms of use.